BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20049491)

  • 1. Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Parapatics S; Gruber G; Nia S; Saletu B
    J Neural Transm (Vienna); 2010 Apr; 117(4):463-73. PubMed ID: 20049491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
    Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
    Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.
    Saletu M; Anderer P; Saletu B; Hauer C; Mandl M; Oberndorfer S; Zoghlami A; Saletu-Zyhlarz G
    Neuropsychobiology; 2000; 41(4):190-9. PubMed ID: 10828728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.
    Happe S; Sauter C; Klösch G; Saletu B; Zeitlhofer J
    Neuropsychobiology; 2003; 48(2):82-6. PubMed ID: 14504416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
    Razazian N; Azimi H; Heidarnejadian J; Afshari D; Ghadami MR
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):271-8. PubMed ID: 25758874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for chronic kidney disease-associated restless legs syndrome.
    Gopaluni S; Sherif M; Ahmadouk NA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
    Allen R; Becker PM; Bogan R; Schmidt M; Kushida CA; Fry JM; Poceta JS; Winslow D
    Sleep; 2004 Aug; 27(5):907-14. PubMed ID: 15453549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
    Garcia-Borreguero D; Larrosa O; de la Llave Y; Verger K; Masramon X; Hernandez G
    Neurology; 2002 Nov; 59(10):1573-9. PubMed ID: 12451200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
    Micozkadioglu H; Ozdemir FN; Kut A; Sezer S; Saatci U; Haberal M
    Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
    Rosenberg RP; Hull SG; Lankford DA; Mayleben DW; Seiden DJ; Furey SA; Jayawardena S; Roth T
    J Clin Sleep Med; 2014 Oct; 10(10):1093-100. PubMed ID: 25317090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin.
    Happe S; Klösch G; Saletu B; Zeitlhofer J
    Neurology; 2001 Nov; 57(9):1717-9. PubMed ID: 11706121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
    Iftikhar IH; Alghothani L; Trotti LM
    Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
    Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
    Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
    Furey SA; Hull SG; Leibowitz MT; Jayawardena S; Roth T
    J Clin Sleep Med; 2014 Oct; 10(10):1101-9. PubMed ID: 25317091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
    Winkelman JW; Jaros MJ
    Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.